Agenus Inc. (AGEN) Social Stream



Agenus Inc. (AGEN): $2.13

-0.11 (-4.91%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

AGENUS INC (AGEN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AGEN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 3 $11 $7 $9 $2.44 268.85%
2021-12-16 4 $12 $7 $10 $2.44 309.84%
2022-03-01 4 $12.001 $7 $10 $2.44 309.84%
2022-04-13 4 $14 $7 $9.666 $2.44 296.15%
2022-05-11 3 $8 $7 $7.5 $2.44 207.38%
2022-08-09 3 $8 $6 $7 $2.44 186.89%

The Trend in the Analyst Price Target


AGEN's average price target has moved up $0.5 over the prior 14 months.

AGEN reports an average of 188.04% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-19 2 12 8 10.000 5.83 71.53%
2021-11-10 4 11 7 9.000 4.33 107.85%
2021-12-16 4 12 7 10.000 3.32 201.2%
2022-04-13 3 14 7 9.666 2.44 296.15%
2022-04-13 4 14 7 9.666 2.44 296.15%

AGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


AGEN's average broker recommendation rating improved by 0 over the prior 35 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, AGENUS INC's average analyst price target is greater than 66.15% of them.
  • In the context of all US stocks, AGENUS INC's upside potential (average analyst target price relative to current price) is higher than 695.58% of them.
  • In terms of how AGENUS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 112.4% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AGENUS INC's variance in analysts' estimates is lower than -121.01% of them.

Stocks similar to AGENUS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ADVM, ADMA, and ADAP.

Is AGEN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5483 seconds.